Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
0.7400
Dollar change
-0.1630
Percentage change
-18.05
%
Index- P/E- EPS (ttm)-0.36 Insider Own14.48% Shs Outstand54.24M Perf Week-26.00%
Market Cap33.16M Forward P/E- EPS next Y-0.15 Insider Trans0.00% Shs Float46.76M Perf Month-29.52%
Income-18.67M PEG- EPS next Q-0.06 Inst Own31.89% Short Float2.88% Perf Quarter-16.97%
Sales37.74M P/S0.88 EPS this Y53.91% Inst Trans-8.19% Short Ratio13.07 Perf Half Y-18.65%
Book/sh0.24 P/B3.10 EPS next Y47.46% ROA-39.15% Short Interest1.35M Perf Year-47.89%
Cash/sh0.13 P/C5.83 EPS next 5Y- ROE-118.50% 52W Range0.70 - 2.15 Perf YTD-33.33%
Dividend Est.- P/FCF- EPS past 5Y-2.64% ROI-47.42% 52W High-65.58% Beta0.52
Dividend TTM- Quick Ratio1.58 Sales past 5Y13.13% Gross Margin62.71% 52W Low5.71% ATR (14)0.09
Dividend Ex-Date- Current Ratio1.97 EPS Y/Y TTM33.06% Oper. Margin-57.21% RSI (14)24.69 Volatility15.87% 8.25%
Employees186 Debt/Eq2.06 Sales Y/Y TTM1.80% Profit Margin-49.47% Recom2.00 Target Price10.00
Option/ShortYes / Yes LT Debt/Eq2.03 EPS Q/Q79.30% Payout- Rel Volume5.37 Prev Close0.90
Sales Surprise-9.39% EPS Surprise-45.45% Sales Q/Q6.58% EarningsNov 07 AMC Avg Volume103.16K Price0.74
SMA20-26.39% SMA50-34.67% SMA200-25.47% Trades Volume515,640 Change-18.05%
Date Action Analyst Rating Change Price Target Change
Sep-07-23Initiated B. Riley Securities Buy $4
Oct-14-21Resumed B. Riley Securities Buy $10
Sep-17-20Initiated Jefferies Buy $15
Sep-01-20Initiated SVB Leerink Outperform $15
Aug-08-17Reiterated Maxim Group Buy $10 → $12
Oct-26-16Initiated Aegis Capital Buy
May-24-16Initiated Maxim Group Buy $8
Oct-29-15Upgrade WBB Securities Speculative Buy → Buy $13 → $13
May-12-15Reiterated MLV & Co Buy $28 → $21
Apr-01-15Reiterated MLV & Co Buy $28 → $30
Today 07:30AM
Nov-08-24 04:03PM
Nov-07-24 05:58PM
04:05PM
Nov-06-24 07:54AM
07:00AM Loading…
Nov-04-24 07:00AM
Oct-22-24 07:00AM
Oct-17-24 07:00AM
Oct-09-24 06:19PM
Oct-01-24 07:00AM
Aug-27-24 07:00AM
Aug-16-24 04:05PM
Aug-13-24 05:45PM
04:19PM
04:18PM
07:00AM Loading…
Aug-07-24 07:00AM
Aug-01-24 07:00AM
Jul-30-24 02:00AM
Jul-29-24 08:00AM
Jul-17-24 07:00AM
Jul-02-24 07:00AM
Jun-24-24 07:00AM
Jun-13-24 07:00AM
Jun-05-24 07:00AM
Jun-04-24 07:00AM
May-10-24 12:10PM
May-09-24 04:24PM
04:17PM
May-02-24 07:00AM
Apr-26-24 07:00AM
07:00AM Loading…
Apr-17-24 07:00AM
Mar-15-24 10:14AM
06:28AM
Mar-14-24 09:53PM
04:39PM
Mar-06-24 07:00AM
Feb-08-24 07:00AM
Jan-17-24 07:15AM
Dec-28-23 07:00AM
Dec-16-23 07:01AM
Dec-13-23 09:15AM
Nov-10-23 09:42AM
08:52AM
Nov-09-23 05:47PM
04:15PM
Oct-27-23 07:00AM
Oct-05-23 07:00AM
Sep-27-23 07:00AM
Sep-21-23 09:35AM
Sep-19-23 07:00AM
Sep-11-23 11:32AM
Sep-01-23 04:43PM
Aug-31-23 07:00AM
Aug-14-23 07:00AM
Aug-03-23 09:10AM
Aug-02-23 09:02AM
Aug-01-23 04:23PM
04:15PM
Jul-31-23 07:31AM
Jul-26-23 07:00AM
Jul-19-23 07:00AM
Jul-11-23 07:00AM
Jul-09-23 09:00AM
Jul-07-23 07:07AM
Jun-15-23 07:00AM
Jun-05-23 09:00AM
May-05-23 07:18AM
May-04-23 10:31AM
May-03-23 07:42AM
May-02-23 04:23PM
04:15PM
Apr-26-23 07:00AM
Apr-20-23 07:00AM
Apr-19-23 07:00AM
Apr-17-23 10:47AM
Mar-29-23 08:30AM
Mar-22-23 08:09AM
Mar-20-23 07:38AM
Mar-17-23 09:10AM
Mar-14-23 07:00AM
Mar-13-23 02:53AM
Mar-10-23 10:33AM
Mar-09-23 04:15PM
Mar-07-23 07:00AM
Feb-27-23 07:00AM
Feb-24-23 07:00AM
Feb-21-23 06:22AM
Feb-15-23 08:20AM
Jan-31-23 07:15AM
Jan-29-23 09:58AM
Jan-23-23 07:00AM
Jan-17-23 07:00AM
Jan-12-23 07:16AM
Dec-29-22 07:00AM
Dec-21-22 07:00AM
Nov-17-22 05:21AM
Nov-14-22 07:00AM
Nov-09-22 05:26AM
Nov-03-22 08:15PM
04:15PM
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sobel Alan D.DirectorDec 13 '23Buy1.3322,55730,001101,857Dec 15 04:35 PM
Deliargyris EfthymiosChief Medical OfficerDec 13 '23Buy1.3322,55730,001348,433Dec 15 04:34 PM
Capponi VincentPresident & COODec 13 '23Buy1.3318,79725,000584,134Dec 15 04:34 PM
BATOR MICHAEL G.DirectorDec 13 '23Buy1.3337,59450,000125,394Dec 15 04:33 PM
Jones Edward RaymondDirectorDec 13 '23Buy1.337,51910,00088,834Dec 15 04:32 PM
BLOCH KATHLEEN P.Chief Financial OfficerDec 13 '23Buy1.3337,59450,000467,941Dec 15 04:32 PM
Kim JinyDirectorDec 13 '23Buy1.337,51910,00077,819Dec 15 04:31 PM
Chan Phillip P.Chief Executive OfficerDec 13 '23Buy1.3375,188100,0001,068,704Dec 15 04:30 PM